Inventor · disambiguated record
Aleem Gangjee
Also filed as: GANGJEE ALEEM
86 granted patents·13 pending applications·437 citations·filing 1992–2024
99Inventor score
Files withUNIV HOLY GHOST DUQUESNE72GANGJEE ALEEM17DUQUESNE UNIV OF THE HOLY GHOST6DUGUESNE UNIVERSITY OF THE HOL1Duquesne Univversity of the Holy Spirit1
Top patents by PatentIndex Score
99 records- 0196US5958930APyrrolo pyrimidine and furo pyrimidine derivativesUNIV HOLY GHOST DUQUESNE·Filed 1998·Granted Sep 28, 1999·84 cites·23 claims
- 0294US7982035B2Tricyclic compounds having antimitotic and/or antitumor activity and methods of use thereofUNIV HOLY GHOST DUQUESNE·Filed 2008·Granted Jul 19, 2011·17 cites·2 claims
- 0393US8871776B2Tricyclic compounds having cytostatic and/or cytotoxic activity and methods of use thereofGANGJEE ALEEM·Filed 2012·Granted Oct 28, 2014·14 cites·4 claims
- 0493US7960400B2Tricyclic compounds having cytostatic and/or cytotoxic activity and methods of use thereofUNIV HOLY GHOST DUQUESNE·Filed 2007·Granted Jun 14, 2011·14 cites·6 claims
- 0593US6518426B1Pyrimidine derivatives and methods of making and using these derivativesUNIV HOLY GHOST DUQUESNE·Filed 2000·Granted Feb 11, 2003·22 cites·10 claims
- 0692US8309564B2Tricyclic compounds having antimitotic and/or antitumor activity and methods of use thereofGANGJEE ALEEM·Filed 2011·Granted Nov 13, 2012·11 cites·3 claims
- 0792US5508281ADerivatives of pyrido [2,3-d] and [3,2-d] pyrimidine and methods of using these derivativesUNIV HOLY GHOST DUQUESNE·Filed 1994·Granted Apr 16, 1996·37 cites·37 claims
- 0891US9056869B2Tricyclic compounds having antimitotic and/or antitumor activity and methods of use thereofGANGJEE ALEEM·Filed 2011·Granted Jun 16, 2015·9 cites·4 claims
- 0990US10233194B2Pyrimidine compounds and pyrimido indole compounds and methods of useUNIV HOLY GHOST DUQUESNE·Filed 2017·Granted Mar 19, 2019·2 cites·2 claims
- 1090US8946239B2Substituted pyrrolo, -furano, and cyclopentylpyrimidines having antimitotic and/or antitumor activity and methods of use thereofGANGJEE ALEEM·Filed 2008·Granted Feb 3, 2015·8 cites·2 claims
- 1190US7981902B2Substituted pyrrolo[2,3-d]pyrimidines for selectively targeting tumor cells with FR type receptorsUNIV HOLY GHOST DUQUESNE·Filed 2007·Granted Jul 19, 2011·6 cites·19 claims
- 1289US9688690B2Pyrimidine compounds and pyrimido indole compounds and methods of useUNIV HOLY GHOST DUQUESNE·Filed 2015·Granted Jun 27, 2017·2 cites·5 claims
- 1389US8258143B2Methods of using substituted pyrrolo[2,3-d]pyrimidines for targeting tumor cells and treating cancerGANGJEE ALEEM·Filed 2007·Granted Sep 4, 2012·5 cites·25 claims
- 1488US8552014B2Methods of using selective chemotherapeutic agents for targeting tumor cellsGANGJEE ALEEM·Filed 2012·Granted Oct 8, 2013·4 cites·25 claims
- 1587US9458167B2Tricyclic compounds having antimitotic and/or antitumor activity and methods of use thereofUNIV HOLY GHOST DUQUESNE·Filed 2015·Granted Oct 4, 2016·3 cites·14 claims
- 1685US9732090B2Bicyclic and tricyclic pyrimidine tyrosine kinase inhibitors with antitubulin activity and methods of treating a patientUNIV HOLY GHOST DUQUESNE·Filed 2015·Granted Aug 15, 2017·3 cites·7 claims
- 1784US8952019B2Methods of using selective chemotherapeutic agents for targeting tumor cellsGANGJEE ALEEM·Filed 2013·Granted Feb 10, 2015·2 cites·25 claims
- 1884US6221872B1Pyrimidine derivatives and methods of making and using these derivativesUNIV HOLY GHOST DUQUESNE·Filed 2000·Granted Apr 24, 2001·8 cites·39 claims
- 1983US9139590B2Bicyclic and tricyclic pyrimidine tyrosine kinase inhibitors with antitubulin activity and methods of treating a patientGANGJEE ALEEM·Filed 2012·Granted Sep 22, 2015·4 cites·76 claims
- 2083US8030319B2Methods for treating cancer and other pathological proliferating disorders by inhibiting mitosis using pyrrolo[2 3-d]pyrimidinesUNIV HOLY GHOST DUQUESNE·Filed 2005·Granted Oct 4, 2011·5 cites·35 claims
- 2183US6962920B2Pyrimidine derivatives and methods of making and using these derivativesUNIV HOLY GHOST DUQUESNE·Filed 2003·Granted Nov 8, 2005·12 cites·4 claims
- 2283US5877178APyrimidine derivatives and methods of making and using these derivativesUNIV HOLY GHOST DUQUESNE·Filed 1996·Granted Mar 2, 1999·20 cites·13 claims
- 2382US6423720B1Pyrimidine compounds and methods for making and using the sameUNIV HOLY GHOST DUQUESNE·Filed 2001·Granted Jul 23, 2002·14 cites·13 claims
- 2482US5346900A5-alkyl-6-[[amino]methyl]pyrido[2,3-D]pyrimidine derivatives and methods of using these derivativesUNIV HOLY GHOST DUQUESNE·Filed 1992·Granted Sep 13, 1994·23 cites·15 claims
- 2581US8314114B2Tricyclic compounds having cytostatic and/or cytoxic activity and methods of use thereofGANGJEE ALEEM·Filed 2011·Granted Nov 20, 2012·3 cites·16 claims
- 2679US8501752B2Methods for treating cancer and other pathological proliferating disorders by inhibiting mitosis using pyrrolo[2,3-d]pyrimidinesGANGJEE ALEEM·Filed 2011·Granted Aug 6, 2013·1 cites·29 claims
- 2779US5939420APyrrolo 2,3d!derivativesUNIV HOLY GHOST DUQUESNE·Filed 1996·Granted Aug 17, 1999·15 cites·23 claims
- 2878US9777012B2Substituted furo[2,3-d]pyrimidines as multi-targeted receptor tyrosine kinase inhibitors and microtubule targeting antitumor agentsUNIV HOLY GHOST DUQUESNE·Filed 2015·Granted Oct 3, 2017·1 cites·7 claims
- 2978US6770652B2Multiple acting anti-angiogenic and cytotoxic compounds and methods for using the sameUNIV HOLY GHOST DUQUESNE·Filed 2001·Granted Aug 3, 2004·11 cites·15 claims
- 3077US11124520B2Cyclopenta[d]pyrimidines and substituted cyclopenta[d]pyrimidines as antitubulin and microtubule targeting agents, monocyclic pyrimidines as tubulin inhibitors, and pyrrolopyrimidines as targeted antifolates and tubulin and multiple receptor tyrosine kinase inhibitor and antitumor agentsUNIV HOLY GHOST DUQUESNE·Filed 2019·Granted Sep 21, 2021·0 cites·10 claims
- 3177US11078214B2Monocyclic thieno, pyrido, and pyrrolo pyrimidine compounds and methods of use and manufacture of sameUNIV HOLY GHOST DUQUESNE·Filed 2019·Granted Aug 3, 2021·0 cites·12 claims
- 3277US10676483B2Tricyclic compounds having antimitotic and/or antitumor activity and methods of use thereofUNIV HOLY GHOST DUQUESNE·Filed 2019·Granted Jun 9, 2020·0 cites·2 claims
- 3376US11840539B2Substituted pyrrolo,-furano, and cyclopentylpyrimidines having antimitotic and/or antitumor activity and methods of use thereofUNIV HOLY GHOST DUQUESNE·Filed 2021·Granted Dec 12, 2023·0 cites·4 claims
- 3476US11091500B2Tricyclic compounds having antimitotic and/or antitumor activity and methods of use thereofUNIV HOLY GHOST DUQUESNE·Filed 2019·Granted Aug 17, 2021·0 cites·1 claims
- 3576US6537999B2Pyrimidine derivatives and methods of making and using these derivativesUNIV HOLY GHOST DUQUESNE·Filed 2001·Granted Mar 25, 2003·7 cites·21 claims
- 3676US5866580AQuinazoline derivatives and methods of using the sameDUGUESNE UNIVERSITY OF THE HOL·Filed 1997·Granted Feb 2, 1999·16 cites·17 claims
- 3775US11618758B2Bicyclic and tricyclic pyrimidine tyrosine kinase inhibitors with antitubulin activity and methods of treating a patientUNIV HOLY GHOST DUQUESNE·Filed 2020·Granted Apr 4, 2023·0 cites·3 claims
- 3875US11111252B2Pyrimidine compounds and pyrimido indole compounds and methods of useUNIV HOLY GHOST DUQUESNE·Filed 2020·Granted Sep 7, 2021·0 cites·3 claims
- 3975US11001595B2Pyrimidine compounds and pyrimido indole compounds and methods of useUNIV HOLY GHOST DUQUESNE·Filed 2020·Granted May 11, 2021·0 cites·5 claims
- 4075US10947246B2Substituted pyrrolo, -furano, and cyclopentylpyrimidines having antimitotic and/or antitumor activity and methods of use thereofUNIV HOLY GHOST DUQUESNE·Filed 2018·Granted Mar 16, 2021·0 cites·2 claims
- 4175US6696455B1Pyrimidine derivatives and methods of making and using these derivativesUNIV HOLY GHOST DUQUESNE·Filed 2000·Granted Feb 24, 2004·5 cites·26 claims
- 4274US11572363B2Substituted bicyclic pyrimidine compounds with tubulin and multiple receptor inhibitionUNIV HOLY GHOST DUQUESNE·Filed 2020·Granted Feb 7, 2023·0 cites·3 claims
- 4374US2023091810A1First-in-class of shmt2 and mthfd2 inhibitors as antitumor agentsUNIV HOLY GHOST DUQUESNE·Filed 2022·Application pending·0 cites
- 4472US11897886B2Pyrazolo[4,3-d]pyrimidines as antitumor agentsUNIV HOLY GHOST DUQUESNE·Filed 2020·Granted Feb 13, 2024·0 cites·1 claims
- 4572US6420370B1Pyrimidine derivatives and method of making and using derivativesUNIV HOLY GHOST DUQUESNE·Filed 2000·Granted Jul 16, 2002·3 cites·7 claims
- 4671US10774090B2Pyrimidine compounds and pyrimido indole compounds and methods of useUNIV HOLY GHOST DUQUESNE·Filed 2019·Granted Sep 15, 2020·0 cites·3 claims
- 4771US10611767B2Selective proton coupled folate transporter and folate receptor, and GARFTase inhibitor compounds and methods of using the sameUNIV HOLY GHOST DUQUESNE·Filed 2018·Granted Apr 7, 2020·0 cites·7 claims
- 4871US10464944B2Tricyclic compounds having antimitotic and/or antitumor activity and methods of use thereofUNIV HOLY GHOST DUQUESNE·Filed 2018·Granted Nov 5, 2019·0 cites·5 claims
- 4970US11384084B2First-in-class of SHMT2 and MTHFD2 inhibitors as antitumor agentsUNIV HOLY GHOST DUQUESNE·Filed 2020·Granted Jul 12, 2022·0 cites·11 claims
- 5070US11053252B2Selective proton coupled folate transporter and folate receptor, and garftase inhibitor compounds and methods of using the sameUNIV HOLY GHOST DUQUESNE·Filed 2020·Granted Jul 6, 2021·0 cites·4 claims
Showing the top 50 of 99 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Aleem Gangjee files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →